Skip to main content

Medical Treatments for Painful Diabetic Neuropathy

  • Chapter
  • First Online:
Book cover Painful Diabetic Polyneuropathy

Abstract

Diabetes remains the single most common cause of peripheral neuropathy in the United States and other developed countries, affecting millions of patients. Neuropathic pain is a frequent complication in this group, affecting over 25 % and substantially impacting quality of life and function, even when other neurological deficits are mild. Advances in our understanding of the pathophysiology of neuropathic pain have enabled rational testing of a wide array of pharmacological agents which have proven effective in treating diabetic painful neuropathy. Concurrent advances in the broader field of pain medicine have fostered the development of both pain specialists and multidisciplinary clinics which are available for more refractory cases. With these therapeutic options, the vast majority of patients with DPN can be successfully treated with appropriate strategies, and can return to normal occupational and social functioning.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. 2011 national diabetes fact sheet. America Diabetes Association. 2011.

    Google Scholar 

  2. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011. NIH Publication No. 11-3892 Feb 2011.

    Google Scholar 

  3. Navarro A, Saldaña MT, Pérez C, Torrades S, Rejas J. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. BMC Neurol. 2011;11(1):7–17.

    Article  PubMed  Google Scholar 

  4. Hoffman DL, Sadosky A, Alvir J. Cross-national burden of painful diabetic peripheral neuropathy in Asia, Latin America, and the Middle East. Pain Pract. 2009;9(1):35–42.

    Article  PubMed  Google Scholar 

  5. Aristidis V, Rayaz AM. Diabetic neuropathy: clinical management. 2nd ed. Humana Press Inc; Totowa, NJ, 2007.

    Google Scholar 

  6. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. Diabetes Care. 1998;21:855–9.

    Article  PubMed  CAS  Google Scholar 

  7. Gooch C, Podwall D. Diabetic neuropathy: clinical features, etiology and therapy. Curr Neurol Neurosci Rep. 2004;4(1):51–61.

    Article  Google Scholar 

  8. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort. Neurology. 1993;43:817–24.

    Article  PubMed  CAS  Google Scholar 

  9. Töyry JP, Niskanen LK, Länsimies EA, et al. Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke. 1996;27:1316–8.

    Article  PubMed  Google Scholar 

  10. Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001;44:1973–88.

    Article  PubMed  CAS  Google Scholar 

  11. Head KA. Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern Med Rev. 2006;11(4):294–329. 36p.

    PubMed  Google Scholar 

  12. Campbell RK, Duby JJ, Rasmussen KA, et al. Diabetic neuropathy: an intensive review. Am J ealth Syst Pharm. 2004;61:160–73.

    PubMed  Google Scholar 

  13. Argoff CE, Howard S. Pharmacological treatment of diabetic neuropathic pain. Drugs. 2011;71(5):557–89.

    Article  PubMed  Google Scholar 

  14. Max MB, Kishore-Kumar R, Schafer SC, et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain. 1991;45(1):3–9.

    Article  PubMed  CAS  Google Scholar 

  15. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992;326(19):1250–6.

    Article  PubMed  CAS  Google Scholar 

  16. Attal N, Cruccu G, Baron R, European Federation of Neurological Societies, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain. 2010 revision. Eur J Neurol. 2010;17(9):1113.

    Article  PubMed  CAS  Google Scholar 

  17. Gooch C. Neuropathic pain. Merritt’s neurology. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005; p. 545–50.

    Google Scholar 

  18. Eisenberg E, Lurie Y, Braker C, et al. Lamotrigine reduced painful diabetic neuropathy: a randomized, controlled study. Neurology. 2001;57(3):505–9.

    Article  PubMed  CAS  Google Scholar 

  19. Raskin P, Donofrio PD, Rosenthal NR, CAPSS-141 Study Group, et al. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology. 2004;63(5):865–73.

    Article  PubMed  CAS  Google Scholar 

  20. Thienel U, Neto W, Schwabe SK, et al. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. Acta Neurol Scand. 2004;110(4):221–31.

    Article  PubMed  CAS  Google Scholar 

  21. Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo- controlled study. Pain. 2003;106(1–2):151–8.

    Article  PubMed  CAS  Google Scholar 

  22. Argoff CE, Galer BS, Jensen MP, et al. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale. Curr Med Res Opin. 2004;20 Suppl 2:S21–8.

    Article  PubMed  CAS  Google Scholar 

  23. Barbano RL, Herrmann DN, Hart-Gouleau S, et al. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol. 2004;61(6):914–8.

    Article  PubMed  Google Scholar 

  24. Capsaicin Study Group. Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care. 1992;15:159–65.

    Article  Google Scholar 

  25. Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin: a multicenter, double-blind, vehicle-controlled study. Arch Intern Med. 1991;151:2225–9.

    Article  Google Scholar 

  26. Tandan R, Lewis GA, Krusinski PB, et al. Topical capsaicin in painful diabetic neuropathy: controlled study with long-term follow-up. Diabetes Care. 1992;15(1):8–14.

    Article  PubMed  CAS  Google Scholar 

  27. Backonja MM, Malam TP, Vanhove GF, Tobias JK, C102/106 Study Group. NGX-4010, a high concentration capsaicin patch, for the treatment of post herpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension. Pain Med. 2010;11(4):600–8.

    Article  PubMed  Google Scholar 

  28. Hollingshead J, Duhmke RM, Cornblath DR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2006; 3: CD003726. (class I SR).

    Google Scholar 

  29. Freeman R, Raskin P, Hewitt DJ, et al. Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy. Curr Med Res Opin. 2007;23:147–61.

    Article  PubMed  CAS  Google Scholar 

  30. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA. 2005;293(24):3043–52.

    Article  PubMed  CAS  Google Scholar 

  31. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002;59:1015–21.

    Article  PubMed  CAS  Google Scholar 

  32. Dubinsky RM, Miyasak J. Assessment: efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2010;74:173–6.

    Article  PubMed  Google Scholar 

  33. Binder A, Baron R. Utility of transcutaneous electrical nerve stimulation in neurologic pain disorders. Neurology. 2010;74:104–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Clifton L. Gooch M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Vidal, Y., Brock, C., Gooch, C.L. (2013). Medical Treatments for Painful Diabetic Neuropathy. In: Lawson, E., Backonja, M. (eds) Painful Diabetic Polyneuropathy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6299-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6299-6_5

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6298-9

  • Online ISBN: 978-1-4614-6299-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics